Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Tenor Capital Management | 89M | $86B | 0% | Dec 2024 |
|
Weiss Asset Management LP[1 | 79M | $77M | 192% | Dec 2024 |
|
Ing Investment Management | 54M | $52M | 206% | Dec 2024 |
|
Capstone Investment Advisors | 51M | $49M | 10% | Dec 2024 |
|
Steelhead Partners | 50M | $48B | 19% | Dec 2024 |
|
Lazard Asset Management | 46M | $44M | -3% | Dec 2024 |
|
CSS | 34M | $33M | 0% | Dec 2024 |
|
BlackRock | 26M | $25M | 14% | Dec 2024 |
|
Calamos Advisors | 17M | $16M | -1% | Dec 2024 |
|
Highbridge Capital Management | 16M | $16M | -37% | Dec 2024 |
|
State Street Corporation | 13M | $13M | 5% | Dec 2024 |
|
DeepCurrents Investment Group | 13M | $12M | 733% | Dec 2024 |
|
Silverback Asset Management | 13M | $12B | -26% | Dec 2024 |
|
Bank Of Montreal | 11M | $11M | 100% | Dec 2024 |
|
FMR | 7.8M | $7.6M | 7% | Dec 2024 |
|
Royal Bank of Canada | 7.0M | $7.0M | 13% | Dec 2024 |
|
Man Group | 3.2M | $3.0M | 0% | Dec 2024 |
|
MacKay Shields | 2.9M | $2.8M | -11% | Dec 2024 |
|
Leucadia National Corporation | 2.2M | $2.1M | 30% | Dec 2024 |
|
Jpmorgan Chase & Co | 2.1M | $2.0M | -35% | Dec 2024 |
|
Camden Asset Management | 1.9M | $1.8B | -50% | Dec 2024 |
|
Barclays | 1.9M | $1.8M | 362% | Dec 2024 |
|
Axa | 1.8M | $1.7M | 0% | Dec 2024 |
|
Bank of America Corporation | 1.8M | $1.7M | 100% | Dec 2024 |
|
Wells Fargo & Company | 1.7M | $1.6M | -68% | Dec 2024 |
|
Morgan Stanley | 1.1M | $1.0M | -86% | Dec 2024 |
|
Deutsche Bank Aktiengesellschaft | 957k | $922k | -11% | Dec 2024 |
|
Kohlberg Kravis Roberts & Co | 580k | $561M | -31% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 526k | $507k | -66% | Dec 2024 |
|
Russell Investments | 521k | $505k | 0% | Dec 2024 |
|
Bnp Paribas Investment Partners | 500k | $483k | 0% | Dec 2024 |
|
Bank of New York Mellon | 300k | $291k | 0% | Dec 2024 |
|
KBC Group NV | 200k | $194k | 0% | Dec 2024 |
|
Sonora Investment Management Group | 160k | $155k | -99% | Dec 2024 |
|
CNH Partners | 150k | $145k | 0% | Dec 2024 |
|
Calamos Wealth Management | 122k | $118k | -14% | Dec 2024 |
|
Oppenheimer Asset Management | 90k | $87k | -8% | Dec 2024 |
|
Shenkman Capital Management | 63k | $61M | -100% | Dec 2024 |
|
Boussard & Gavaudan Investment Management | 55k | $53M | 0% | Dec 2024 |
|
Lake Street Advisors Group | 53k | $51k | 0% | Dec 2024 |
|
Argent Trust | 25k | $24k | 0% | Dec 2024 |
|
Stephens | 23k | $22k | -49% | Dec 2024 |
|
Balboa Wealth Partners | 17k | $16k | 0% | Dec 2024 |
|
Citigroup | 13k | $13k | 100% | Dec 2024 |
|
Steward Partners Investment Advisory | 4.0k | $3.9k | 100% | Dec 2024 |
|
Us Bancorp | 2.0k | $1.9k | 0% | Dec 2024 |
|
Cassady Schiller Wealth Management | 2.0k | $1.9k | 100% | Dec 2024 |
|
Who sold out of Ionis Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Advent Capital Management | Sep 2024 | 19M | $19M |
Lombard Odier Asset Management | Sep 2024 | 14M | $14M |
Nuveen Asset Management | Sep 2024 | 7.0M | $7.0M |
Schroder Investment Management Group | Sep 2024 | 4.4M | $4.4M |
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | Sep 2024 | 4.3M | $4.2M |
New York State Common Retirement Fund | Sep 2024 | 2.4M | $2.4M |
Ubs Global Asset Management Americas | Sep 2024 | 761k | $759k |
SSI Investment Management | Sep 2024 | 496k | $495k |
Verition Fund Management | Sep 2024 | 405k | $405k |
Jane Street | Sep 2024 | 145k | $144k |
Rsm Us Wealth Management | Sep 2024 | 47k | $47k |
Insigneo Advisory Services | Sep 2024 | 23k | $23k |
Aurum Wealth Management Group | Sep 2024 | 18k | $18k |
Brian McDonald | Sep 2024 | 3.0k | $3.0k |